Witold Kolber

Witold Kolber

Auto-generated profile, based on publicly available information

Witold Kolber

Department of Surgery, Complex of Health Care Centers in Wadowice, Karmelicka 5 St., 34-100 Wadowice, Poland

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
WKWitold Kolber
Witold Kolber
Paulina DumnickaPaulina Dumnicka
Paulina Dumnicka
MMMałgorzata Maraj
Małgorzata Maraj
Beata Kuśnierz-CabalaBeata Kuśnierz-Cabala
Beata Kuśnierz-Cabala
Piotr CeranowiczPiotr Ceranowicz
Piotr Ceranowicz
JWJerzy Walocha
Jerzy Walocha
Acute pancreatitis (AP) in most patients takes a course of self-limiting local inflammation. However, up to 20% of patients develop severe AP (SAP), associated with systemic inflammation and/or pancreatic necrosis. Early prediction of SAP allows for the appropriate intensive treatment of severe cases, which reduces mortality. Serum interleukin-6 (IL-6) has been proposed as a biomarker to assist early diagnosis of SAP, however, most data come from studies utilizing IL-6 measurements with ELISA. Our aim was to verify the diagnostic usefulness of IL-6 for the prediction of SAP, organ failure, and need for intensive care in the course of AP using a fully automated assay. The study included 95 adult patients with AP of various severity (29 mild, 58 moderately-severe, 8 severe) admitted to a hospital within 24 h from the onset of symptoms. Serum IL-6 was measured using electochemiluminescence immunoassay in samples collected on admission and on the next day of hospital stay. On both days, patients with SAP presented the highest IL-6 levels. IL-6 correlated positively with other inflammatory markers (white blood cell and neutrophil counts, C-reactive protein, procalcitonin), the markers of renal injury (kidney injury molecule-1 and neutrophil gelatinase-associated lipocalin), and the markers of endothelial dysfunction (angiopoietin-2, soluble fms-like tyrosine kinase-1). IL-6 on admission significantly predicted SAP, vital organ failure, and the need for intensive care or death, with areas under the receiver operating curve between 0.75 and 0.78, not significantly different from multi-variable prognostic scores. The fully automated assay allows for fast and repeatable measurements of serum IL-6, enabling wider clinical use of this valuable biomarker.

27 September 2018 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
WKWitold Kolber
Witold Kolber
Beata Kuśnierz-CabalaBeata Kuśnierz-Cabala
Beata Kuśnierz-Cabala
Paulina DumnickaPaulina Dumnicka
Paulina Dumnicka
MMMałgorzata Maraj
Małgorzata Maraj
MMMałgorzata Mazur-Laskowska
Małgorzata Mazur-Laskowska
Piotr CeranowiczPiotr Ceranowicz
Piotr Ceranowicz
Severe acute pancreatitis (SAP) concerns 10–20% of acute pancreatitis (AP) patients and is associated with a poor prognosis and high mortality. An early prognosis of the unfavorable outcome, transfer to an intensive care unit (ICU) and the introduction of an adequate treatment are crucial for patients’ survival. Recently, the elevated circulating urokinase-type plasminogen activator receptor (uPAR) has been reported to predict SAP with a high diagnostic accuracy among patients in a tertiary center. The aim of the study was to compare the diagnostic utility of uPAR and other inflammatory markers as the predictors of the unfavorable course of AP in patients admitted to a secondary care hospital within the first 24 h of the onset of AP. The study included 95 patients, eight with a SAP diagnosis. Serum uPAR was measured on admission and in the two subsequent days. On admission, uPAR significantly predicted organ failure, acute cardiovascular failure, acute kidney injury, the need for intensive care, and death. The diagnostic accuracy of the admission uPAR for the prediction of SAP, organ failure, and ICU transfer or death was low to moderate and did not differ significantly from the diagnostic accuracy of interleukin-6, C-reactive protein, procalcitonin, D-dimer and soluble fms-like tyrosine kinase-1. In the secondary care hospital, where most patients with AP are initially admitted, uPAR measurements did not prove better than the currently used markers.

1 January 2013
Verified
Journal Article
Closed access
WKWitold Kolber
Witold Kolber
MSMateusz Sporek
Mateusz Sporek
Paulina DumnickaPaulina Dumnicka
Paulina Dumnicka
Beata Kuśnierz-CabalaBeata Kuśnierz-Cabala
Beata Kuśnierz-Cabala
MKMarek Kuzniewski
Marek Kuzniewski
JKJan Kulig
Jan Kulig


1 January 2013
Verified
Journal Article
Closed access
MSMateusz Sporek
Mateusz Sporek
WKWitold Kolber
Witold Kolber
Beata Kuśnierz-CabalaBeata Kuśnierz-Cabala
Beata Kuśnierz-Cabala
Paulina DumnickaPaulina Dumnicka
Paulina Dumnicka
AGAnna Gurda-Duda
Anna Gurda-Duda
JKJan Kulig
Jan Kulig